Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB26FUJLT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,679
Award facts
- Contract value 100% obligated
- $5,678.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 15, 2025, for the supply of NUCALA 100 mg/mL auto-injectors. The contract, valued at $5,678.70 with a firm fixed-price structure, carries an ultimate completion date of October 16, 2025, and includes no set-aside designation. The place of performance is the vendor's location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion blanket contract valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. NUCALA (mepolizumab), a biologic auto-injector treatment, represents one of many specialized pharmaceutical items the company supplies through this master contract vehicle, which encompasses prescription medications, biologics, over-the-counter drugs, and medical consumables. As a consistent federal pharmaceutical supplier, DMS Pharmaceutical Group has established itself as a key participant in the Defense Logistics Agency's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB26FUJLT?
SPE2DB26FUJLT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 15, 2025.
How much is contract SPE2DB26FUJLT worth?
The government has obligated $5,679 on SPE2DB26FUJLT.
Is contract SPE2DB26FUJLT an order under another contract?
Yes. SPE2DB26FUJLT is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB26FUJLT competed?
The extent of competition for SPE2DB26FUJLT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award